| Chiral alkyl halides: Underexplored motifs in medicine B Gál, C Bucher, NZ Burns Marine drugs 14 (11), 206, 2016 | 91 | 2016 |
| Discovery of an inhibitor of the production of the Pseudomonas aeruginosa virulence factor pyocyanin in wild-type cells B Morkunas, B Gal, WRJD Galloway, JT Hodgkinson, BM Ibbeson, ... Beilstein journal of organic chemistry 12 (1), 1428-1433, 2016 | 22 | 2016 |
| Enantiospecific solvolytic functionalization of bromochlorides AJ Burckle, B Gál, FJ Seidl, VH Vasilev, NZ Burns Journal of the American Chemical Society 139 (38), 13562-13569, 2017 | 20 | 2017 |
| Enantioselective Total Synthesis of the Archaeal Lipid Parallel GDGT‐0 (Isocaldarchaeol) ID Falk, B Gál, A Bhattacharya, JH Wei, PV Welander, SG Boxer, ... Angewandte Chemie 133 (32), 17632-17637, 2021 | 6 | 2021 |
| Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α JW Beatty, SL Drew, M Epplin, JTA Fournier, GAL Balint, T Guney, ... US Patent 11,407,712, 2022 | 1 | 2022 |
| Abstract P206: AB521 potently and selectively inhibits pro-tumorigenic gene transcription by Hypoxia-Inducible Factor (HIF)-2α in vitro and in vivo KES Gauthier, D Piovesan, S Cho, KV Lawson, PG Schweickert, A Lopez, ... Molecular Cancer Therapeutics 20 (12_Supplement), P206-P206, 2021 | 1 | 2021 |
| Tetralin and tetrahydroquinoline compounds as inhibitors of hif-2alpha JW BEATTY, SL DREW, M EPPLIN, JTA FOURNIER, GAL Balint, ... | 1 | 2021 |
| Discovery and characterization of AB521, a novel, potent, and selective hypoxia-inducible factor (HIF)-2α inhibitor KV Lawson, KES Gauthier, AK Mailyan, JT Fournier, JW Beatty, SL Drew, ... Cancer Res. 81, 1206, 2021 | 1 | 2021 |
| Compounds as inhibitors of axl JW Beatty, CN Foley, GAL Balint, M Lamani, MR Leleti, DH Miles, ... US Patent App. 18/341,844, 2023 | | 2023 |
| Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha JW Beatty, SL Drew, M Epplin, JTA Fournier, GAL Balint, T Guney, ... US Patent 11,787,762, 2023 | | 2023 |
| Inhibitors of hif-2alpha and methods of use thereof JW Beatty, SL Drew, M Epplin, J Fournier, GAL Balint, C Hardman, ... US Patent App. 18/050,557, 2023 | | 2023 |
| Compuestos de tetralina y tetrahidroquinolina como inhibidores de hif-2alfa G Tezcan, WB Joel, E Matthew, TAF Jeremy, G Balint, TH Karl, H Clayton, ... | | 2022 |
| Compuestos de tetralina y tetrahidroquinolina como inhibidores de hif-2alfa JW Beatty, MR Leleti, Y Su, KT Haelsig, SD Jacob, JL Jeffrey, SL Drew, ... | | 2022 |
| Enantioselective Total Synthesis of the Archaeal Lipid Parallel GDGT-0 ID Falk, B Gál, A Bhattacharya, JH Wei, PV Welander, S Boxer, N Burns | | 2021 |
| 583 Novel, potent, and selective inhibitors of hypoxia-inducible factor (HIF)-2α reverse pro-tumorigenic transcriptional programming in cancer, stromal, and immune cells KS Gauthier, D Piovesan, K Lawson, S Cho, A Udyavar, J Chan, A Chen, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
| Stereospecific Functionalization of Vicinal Dihalides and Efforts Toward the Total Synthesis of Archaeal Lipids B Gal Stanford University, 2019 | | 2019 |
| Enantioselective Total Synthesis of the Archaeal Lipid GDGT-0 ID Falk, B Gál, A Bhattacharya, JH Wei, PV Welander, SG Boxer, ... | | |
